Title: Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R.
Citation: Respir Med
2023;211:107216.
Country: Spain | Indication: Asthma
http://tago.ca/36958514
Title: Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R.
Citation: Respir Med
2023;211:107216.
Country: Spain | Indication: Asthma
Title: Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R.
Citation: Respir Med
2023;211:107216.
Country: Spain | Indication: Asthma